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The Saccharomyces cerevisiae SWI-SNF complex is a 2-MDa protein assembly that is required for the function
of many transcriptional activators. Here we describe experiments on the role of the SWI-SNF complex in
activation of transcription by the yeast activator GAL4. We find that while SWI-SNF activity is not required
for the GAL4 activator to bind to and activate transcription from nucleosome-free binding sites, the complex
is required for GAL4 to bind to and function at low-affinity, nucleosomal binding sites in vivo. This SWI-SNF
dependence can be overcome by (i) replacing the low-affinity sites with higher-affinity, consensus GAL4 binding
sequences or (ii) placing the low-affinity sites into a nucleosome-free region. These results define the criteria
for the SWI-SNF dependence of gene expression and provide the first in vivo evidence that the SWI-SNF
complex can regulate gene expression by modulating the DNA binding of an upstream activator protein.
The SWI-SNF complex is required for the expression of a
number of diversely regulated genes in the yeast Saccharomy-
ces cerevisiae. The results of genetic experiments indicate that
the SWI-SNF requirement reflects the ability of the complex to
antagonize chromatin-mediated transcriptional repression
(26). In these studies, mutations in genes that encode chroma-
tin components, including HHT1 (encoding histone H3),
HHF1 (encoding histone H4), and SIN1 (encoding an HMG-
1-like protein which is thought to be a chromatin component),
were found to alleviate the transcriptional defects of swi mu-
tants (14, 15). In addition, alteration of relative histone levels
by deletion of one of the two endogenous HTA1-HTB1 gene
clusters (encoding histones H2A and H2B) is also able to
partially restore transcriptional activity to swi-snf cells (12).
These results suggest that the SWI-SNF complex acts to pro-
mote the expression of genes within the context of a compact
eukaryotic genome.
The primary level of chromatin architecture in vivo is the
nucleosome. The results of in vivo and in vitro studies indicate
that nucleosomes inhibit transcription by competing with tran-
scription factors for occupancy of DNA binding sites (for a
review, see reference 27). In vitro, nucleosomes can inhibit
transcription initiation either by blocking access of the general
transcription machinery to promoter sequences or by hinder-
ing the binding of upstream activator proteins. It is not known
at present which of these steps might be overcome by the
SWI-SNF complex in vivo. The results of biochemical studies
have shown that yeast or human SWI-SNF complex can stim-
ulate the binding of an activator protein to a nucleosomal
binding site (5, 16). Furthermore, the purified human SWI-
SNF complex can facilitate the binding of the general tran-
scription factor TATA box binding protein (TBP) to a posi-
tioned nucleosome (13). Therefore, the SWI-SNF complex
may function at one or more discrete steps to facilitate gene
expression in vivo.
In this study, we address the ability of the SWI-SNF complex
to facilitate the binding of a transcriptional activator to up-
stream activation sites (UASs). To do this, we monitored the
transcriptional activity and DNA binding of the yeast activator
GAL4 to derivatives of the UAS of the divergently transcribed
GAL1 and GAL10 genes. These UAS derivatives differ in the
affinity of the GAL4 binding sites as well as the nucleosomal
context of these sites. We find that the SWI-SNF complex is
required for GAL4 to activate transcription from a promoter
containing two low-affinity, nucleosomal binding sites in vivo.
In addition, we show that the SWI-SNF dependence of this
promoter reflects, in part, the ability of the complex to facili-
tate GAL4 binding to these nucleosomal sites.
MATERIALS AND METHODS
b-Galactosidase assays. Strains were grown in minimal medium containing
2% galactose, 0.5% sucrose, and all the amino acids except histidine to an optical
density at 600 nm (OD600) of 0.5 to 0.9. Assays were performed (23) on three
transformants, and Miller units (19) were averaged. Standard deviations were
,25%. b-Galactosidase activity from all strains in the absence of GAL4 expres-
sion was ,1 Miller unit.
In vivo footprinting. Intact cells were treated with dimethyl sulfate (DMS),
and the methylated DNA was isolated essentially as previously described (10),
except final pellets were dissolved in water and quantitated with a spectropho-
tometer. DNA samples were then digested with HaeIII and analyzed via a cyclic
primer extension reaction (1) using a labeled oligonucleotide. Primer extension
products were extracted with chloroform-isoamyl alcohol (24:1), precipitated,
and electrophoresed on a 5% National Diagnostics sequencing gel. The gel was
dried and exposed to film for 12 to 48 h. For a control for spurious primer
extension products, DNA from a strain that was not treated with DMS was also
prepared. Footprinting at the wild-type GAL1,10 UAS (see Fig. 2) was analyzed
by using an oligonucleotide with the following sequence: 59-GAG CCC CAT
TAT CTT AGC-39, which anneals to a sequence located 60 bp upstream of
GAL4 binding site 1. Footprinting at the integrated reporter loci (see Fig. 3) was
analyzed by using an oligonucleotide with the following sequence: 59-CCG GCT
CGT ATG TTG TGT GG-39. This oligonucleotide anneals to the unique pUC
sequences located upstream of the GAL4 binding sites in the reporters (see
below).
Indirect end labeling. Nuclei were prepared as described previously (22). To
prepare free DNA, 80 ml of 10% sodium dodecyl sulfate (SDS) and 30 ml of
20-mg/ml proteinase K were added to a 1-ml aliquot of nuclei (approximately 5 3
109 cell equivalents), and the sample was incubated at 37°C for 2 h. Lysed nuclei
were treated with 180 ml of 5 M potassium acetate on ice for 1 h and subjected
to centrifugation, and the supernatant was precipitated with isopropanol. This
DNA sample was resuspended in water and reprecipitated with ethanol. The
resultant free DNA was resuspended in 1 ml of buffer D2 (10 mM HEPES [pH
7.3], 5 mM MgCl2, 2 mM CaCl2). Free DNA and nuclei samples (approximately
1.7 3 109 cell equivalents in 300-ml aliquots) were digested with 0 to 50 U of
micrococcal nuclease (MNase) for 5 min at 37°C. Reactions were halted by
adding 26 ml of 10% SDS and 10 ml of 20-mg/ml proteinase K and incubating the
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mixtures at 37°C for 2 h. Samples were treated with 60 ml of 5 M potassium
acetate on ice for 1 h and subjected to centrifugation, and the supernatant was
precipitated with isopropanol. DNA was then digested with either ClaI (see Fig.
4A and B) or EcoRI (see Fig. 4C) in the presence of RNase. Digested fragments
were extracted with buffered phenol, and the aqueous layer was precipitated with
ethanol. Final pellets were electrophoresed on a 1.5% agarose gel overnight.
DNA was transferred to a nylon membrane, and blots were probed with an
internally labeled 870-bp lacZ fragment (see Fig. 4A and B) or an internally
labeled 550-bp fragment from the GAL1 gene (see Fig. 4C).
HgaI restriction enzyme accessibility assay. Permeabilized spheroplasts were
prepared from exponentially growing cells (OD600 of 0.6, in glucose medium) by
treatment with yeast lyticase (24). Briefly, cells were harvested, resuspended in
1/10 culture volume of prespheroplasting buffer (100 mM Tris [pH 8.0], 60 mM
b-mercaptoethanol), and shaken for 10 min at room temperature. Cells were
harvested and resuspended in 1/20 culture volume of spheroplasting buffer (0.7
M sorbitol, 0.75% yeast extract, 1.5% peptone, 10 mM Tris [pH 7.5], 10 mM
b-mercaptoethanol), lyticase was added, and cells were incubated at 37°C until
the OD600 of cells diluted with water was decreased by 90% (30 to 40 min).
Spheroplasts were harvested by centrifugation, washed once with nystatin buffer
(50 mM NaCl, 1.5 mM CaCl2, 20 mM Tris [pH 8], 1 M sorbitol, 10 mM MgCl2),
and resuspended in 1/150 culture volume of nystatin buffer. Nystatin was added
to a final concentration of 15 mg/ml, and spheroplasts were incubated at 37°C for
5 min. HgaI (New England BioLabs) was added to the permeabilized sphero-
plasts at a concentration of 120 U/ml, and samples were incubated at 37°C for 0
to 30 min. Reactions were stopped by the addition of 1/5 volume of 5% SDS–50
mM EDTA, and DNA was purified as described above (a negative control lacked
HgaI). Purified DNA was digested with HindIII (New England BioLabs), elec-
trophoresed on a 1.5% agarose gel, Southern blotted to a nylon membrane, and
probed with a 500-bp EcoRI fragment from plasmid pLB8 that was internally
labeled by random priming (see Fig. 5). Results were quantitated by phosphor-
imager analysis.
Plasmid and strain construction. The following plasmids have been described
previously: pRY171 (GAL1-lacZ fusion [30]), pEG202 (pLEXA [11]), and
pMA210 (pGAL4) and pSD15 (17). Plasmids pLB7 and pLB8 were constructed
by inserting the 194-bp SmaI-PvuII fragment of pUC18 (29) between the URA3
gene and the GAL4 binding sites of the plasmids pEG44 and pEG28, respec-
tively (9). Plasmid pEG28 contains GAL4 binding sites 3 and 4 positioned 190 bp
upstream of the GAL1 TATA element. These sites are separated by 62 bp
(center-to-center distance). Plasmid pEG44 contains two synthetic, consensus
GAL4 binding sites positioned 150 bp upstream of the GAL1 TATA element (9).
These two sites are separated by 32 bp (center-to-center distance). These plas-
mids were targeted for integration at the ura3-52 locus of yeast strains CY524,
CY525, and CY526 (Table 1) by digestion with ApaI. A DNA fragment contain-
ing the 5S nucleosome positioning element (NPE) of sea urchin was amplified
from plasmid pICN5S182 (gift from Jerry Workman) by PCR using the following
primers: 59-CCACGAATAACTTCCAGGG-39 and 59-CCCCGAGGAATTAA
GTAC-39 (18). The 182-bp PCR product was inserted into plasmid pLB8, 20 bp
upstream of GAL4 binding site 3 (see Fig. 1). This new plasmid, called pLB16,
was targeted for integration at the ura3-52 locus of CY524, CY525, and CY526
by digestion with ApaI. Yeast transformations were performed via the lithium
acetate method described previously (8).
RESULTS
SWI-SNF activity is required for transcriptional activation
by GAL4 at some promoters. Isogenic SWI1 and swi2 strains
that contain similar single-copy integrated reporters were con-
structed and are shown schematically in Fig. 1A. Strains
CY353 (SWI1) and CY366 (swi12) contain a GAL1,10 UAS
reporter consisting of four GAL4 binding sites upstream of a
GAL1-lacZ fusion gene (reporter a). Strains CY401 (SWI1)
and CY422 (swi12) contain a derivative of this reporter that
contains only two of these low-affinity GAL4 binding sites
(sites 3 and 4; reporter b); strains CY532 (SWI1) and CY534
(swi12) contain a version of reporter b that contains 192 bp of
additional plasmid sequences 20 bp upstream of GAL4 site 3
(reporter c); strains CY528 (SWI1) and CY530 (swi12) con-
tain a reporter which contains two high-affinity, consensus
GAL4 binding sites in place of the two low-affinity sites (re-
porter d) (9). b-Galactosidase assays were performed on these
strains to monitor GAL4 transcriptional activity either in the
presence of endogenous concentrations of GAL4 (pLEXA
columns) or under conditions in which GAL4 is overexpressed
(pGAL4 columns) (Fig. 1A).
In the absence of functional SWI-SNF complex, transcrip-
tional activation by GAL4 from the wild-type GAL1,10 UAS
region is reduced only 1.5-fold from the activity in the respec-
tive wild-type strain (Fig. 1A, reporter a). This result is con-
sistent with a previous study in which it was found that GAL1
expression was only weakly affected by swi-snf mutations (21).
In contrast, GAL4 activity on the two reporters with two low-
affinity GAL4 binding sites is SWI-SNF dependent; transcrip-
tional activity is reduced 22- to 32-fold in the swi12 strains
from that of the wild-type strain (Fig. 1A, reporters b and c).
When these two low-affinity sites are replaced by two high-
affinity, consensus GAL4 binding sites, transcriptional activa-
tion is reduced only 1.3-fold in the swi12 strain from that of the
wild-type strain (Fig. 1A, reporter d).
Strains harboring the two low-affinity site reporters were
also distinct from those carrying the two high-affinity site re-
porters in that lacZ expression was increased 2.5- to 3.5-fold
when GAL4 protein was overexpressed (Fig. 1A, reporters b
and c; also data not shown). The simplest interpretation of this
result is that physiological levels of GAL4 are not sufficient to
fully occupy the two low-affinity sites (9; also see below). Im-
portantly, overexpression of GAL4 does not overcome the
SWI-SNF dependence of this reporter (Fig. 1A, reporters b
and c). It should be noted that the swi1 mutation does not
affect expression of GAL4 from this overexpression plasmid in
this strain background (Fig. 1B) (20).
SWI-SNF is required for GAL4 occupancy of low-affinity
binding sites in vivo. To directly assess the ability of GAL4 to
bind its sites in the different reporter strains in the presence or
absence of SWI-SNF, we used an in vivo DMS footprinting
assay. GAL4 protects guanine residues at each end of its 17-bp
TABLE 1. Yeast strains used in this study
Strain Genotype
CY257 ..............MATa swi1D::LEU2 lys2-801 ade2-101 leu2-D1 his3-
D200 ura3-D99
CY296 ..............MATa gal4D::LEU2 lys2-801 ade2-101 leu2-D1 his3-
D200 ura3-D99
CY297 ..............MATa gal4D::LEU2 swi1D::LEU2 lys2-801 ade2-101
leu2-D1 his3-D200 ura3-D99
CY341 ..............MATa lys2-801 ade2-101 leu2-D1 his3-D200 ura3-D99
CY353 ..............Same as CY524 but contains URA3::pRY171
(GAL1,10)
CY366 ..............MATa swi1D::LEU2 ura3-52 ade2-101 his3-D200 leu2-
D1 lys2-801 URA3::pRY171 (GAL1,10)
CY401 ..............Same as CY524 but contains URA3::pEG28 (2 low)a
CY422 ..............Same as CY526 but contains URA3::pEG28 (2 low)
CY524 ..............MATa lys2-801 ade2-101 leu2-D1 his3-D200 ura3-52
CY525 ..............MATa gal4D::LEU2 lys2-801 ade2-101 leu2-D1 his3-
D200 ura3-52
CY526 ..............MATa swi1D::LEU2 lys2-801 ade2-101 leu2-D1 his3-
D200 ura3-52
CY528 ..............Same as CY524 but contains URA3::pLB7 (2 high)b
CY529 ..............Same as CY525 but contains URA3::pLB7 (2 high)
CY530 ..............Same as CY526 but contains URA3::pLB7 (2 high)
CY532 ..............Same as CY524 but contains URA3::pLB8 (2 low;
pUC spacer)
CY533 ..............Same as CY525 but contains URA3::pLB8 (2 low;
pUC spacer)
CY534 ..............Same as CY526 but contains URA3::pLB8 (2 low;
pUC spacer)
CY586 ..............Same as CY524 but contains URA3::pLB16 (2 low;
NPE)
CY587 ..............Same as CY525 but contains URA3::pLB16 (2 low;
NPE)
CY588 ..............Same as CY526 but contains URA3::pLB16 (2 low;
NPE)
a 2 low, two low-affinity GAL4 binding sites.
b 2 high, two high-affinity GAL4 binding sites.
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recognition site both in vivo (10) and in vitro (3). As shown in
Fig. 2, these guanine residues within the four GAL4 binding
sites of the GAL1,10 UAS are protected from DMS methyl-
ation in the presence of GAL4 (lane 3) but are accessible to
methylation in an isogenic gal42 strain (lane 2). Introduction
of GAL4 expression plasmids into the gal42 strain restores
protection of these guanines (lanes 6 and 8), while introduction
of a plasmid expressing the bacterial LexA protein does not
(lane 7). In the absence of SWI-SNF activity, protection of all
four sites is retained (lane 4). Furthermore, as shown in Fig.
3A, GAL4 also protects the guanine residues at each of the two
high-affinity binding sites in the presence (lane 4) and absence
(lane 5) of SWI-SNF. Similar results were obtained in at least
six different experiments with five independent DNA prepara-
tions. These results are consistent with the results of our func-
tional experiments (Fig. 1) in which SWI-SNF is not required
for the activity of GAL4 from either the wild-type GAL1,10
UAS or the two-high-affinity-site reporter.
Figure 3B shows the results of an in vivo footprinting anal-
ysis of the two-low-affinity-site reporter in strains CY532
(SWI1) and CY534 (swi12). We detect little protection of the
two low-affinity sites in our footprinting assay, even in a SWI1
strain (lane 3). As discussed above, this probably reflects the
low occupancy of these sites at physiological GAL4 levels,
because when GAL4 is overexpressed in this SWI1 strain,
protection is restored (lane 5). Overexpression of GAL4 in the
absence of a functional SWI-SNF complex, however, does not
restore complete protection of either low-affinity binding site
(lane 6). This is most apparent at GAL4 site 3, where strong
protection in the SWI1 strain (lane 5) and are only weak
protection in the swi12 strain (lane 6) are observed. Quanti-
tation of these results by phosphorimager analysis indicates
that protection of the relevant guanine residue in site 3 in the
swi12 strain is decreased (40%) from that seen in a wild-type
strain. For an internal control, we also analyzed these samples
for GAL4 binding at the endogenous GAL1,10 UAS locus. In
all cases, we observe complete occupancy of the four GAL4
sites in the presence and absence of SWI-SNF (data not
shown). The lack of complete occupancy at the two low-affinity
sites in the swi12 strain indicates that the SWI-SNF complex
modulates GAL4 binding in vivo.
Introduction of an NPE into a SWI-SNF-dependent pro-
moter region can suppress the requirement for SWI-SNF. The
results of genetic and biochemical experiments have indicated
that SWI-SNF complex facilitates activator function by disrupt-
ing chromatin structure. To assess whether the chromatin
structure of the GAL4 binding sites was related to their SWI-
SNF dependence, a strong NPE was inserted directly upstream
of the two low-affinity binding sites in strains CY532 (SWI1)
and CY534 (swi12). This 182-bp NPE sequence has been
shown previously to translationally and rotationally position a
nucleosome in vivo in yeast (20) (Fig. 4B). Insertion of the
NPE had a dramatic effect on the SWI-SNF dependence of
GAL4 function. While GAL4 transcriptional activity at the
parental two-low-affinity-site reporter was decreased over 20-
fold in the absence of SWI-SNF (Fig. 1A, reporters b and c),
there was less than a 1.5-fold decrease when the NPE was
inserted (Fig. 1A, reporter e). This effect of the NPE is not due
FIG. 1. GAL4 requires functional SWI-SNF complex to activate transcription from two low-affinity binding sites. (A) b-Galactosidase assays were performed on
isogenic SWI1 or swi12 strains harboring the integrated GAL1-lacZ UAS reporter plasmids pRY171 (a), pEG28 (b), pLB8 (c), pLB7 (d), or pLB16 (e). GAL4 binding
sites are denoted by the small black boxes. GAL4 sites numbered 1 to 4 indicate sites from the GAL1,10 UAS region; GAL4 sites numbered 17 indicate synthetic,
consensus GAL4 binding sites. Strains contained plasmids that overexpressed either the bacterial LexA DNA binding domain (pEG202) or the full-length GAL4 protein
(pMA210). Numbers in parentheses show activities as percentages of the wild-type levels. b-Galactosidase activities of all reporters were ,1 Miller unit in the absence
of GAL4. Drawings are not to scale. n.d., not determined. (B) Western blot analysis of GAL4 levels. Whole-cell extracts (21) were prepared from equal numbers of
SWI1 (CY296) and swi12 (CY297) cells containing the GAL4 overexpression plasmid pMA210. Expression of GAL4 protein (indicated by the arrow) was identified
by Western blotting using an antibody directed against the C terminus of GAL4 (21).
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simply to insertion of foreign DNA sequences directly up-
stream of the two low-affinity GAL4 binding sites, as insertion
of 192 bp of pUC plasmid sequences at an identical position
does not alter the SWI-SNF dependence of GAL4 activity (Fig.
1A, reporters b and c).
Nucleosomal context of GAL4 binding sites dictates SWI-
SNF dependence. The results of functional experiments de-
scribed above suggest that the SWI-SNF dependence of GAL4
can be modulated by nucleosome positioning. In the case of
the GAL1,10 locus, the four GAL4 binding sites are main-
tained in a constitutive nucleosome-free region which is
flanked on both sides by an array of positioned nucleosomes (6,
7) (Fig. 4). This precise nucleosome positioning at the
GAL1,10 locus is believed to require the GRF2 protein which
binds to a sequence that overlaps GAL4 binding sites 1 and 2
(4, 7). The GAL1,10 UAS derivatives that we have analyzed in
this study (Fig. 1A, reporters b to e) lack this GRF2 binding
site, and therefore, they may not maintain nucleosome posi-
tioning surrounding the GAL4 binding sites. To confirm this
possibility, we analyzed the chromatin structure of the two-
low-affinity-site reporters (with and without an NPE) and com-
pared these structures to that of the GAL1 locus in the same
strains.
Nuclei and free DNA were prepared from the SWI1 strain
CY532, which contains the parental two-low-affinity-site re-
porter (without an NPE), and samples were analyzed by
MNase digestion and indirect end labeling. First, we analyzed
the chromatin structure at the GAL1 locus in this reporter
strain (Fig. 4C). Comparison of the MNase cleavage patterns
for free and chromatin DNA samples reveals a repeating pat-
tern of MNase protections (each about 140 bp in size) flanked
on each side by MNase-hypersensitive sites. These results are
essentially identical to a previous study (6) and are consistent
with an array of positioned nucleosomes downstream of the
nucleosome-free GAL4 binding sites.
A similar analysis of the two-low-affinity-site reporter locus
(without an NPE) yielded very different results (Fig. 4A). In
the region upstream of the two GAL4 binding sites, the MNase
digestion pattern of the chromatin sample is similar to the
pattern of digestion of free DNA, although we do reproducibly
observe several preferred cleavage sites in free DNA that ap-
pear to be enhanced in the chromatin sample. Importantly, the
MNase cleavage sites directly upstream and adjacent to the
GAL4 binding sites are cleaved with equal efficiency in the free
and chromatin DNA samples. A region of about 80 bp that
contains the GAL4 binding sites is not cleaved efficiently in
either the free or chromatin DNA samples; this is due to the
inherent sequence specificity of MNase I and is not due to a
positioned nucleosome (6). In addition, this protected region is
not flanked on both sides by hypersensitive sites. Directly
downstream of the GAL4 binding sites, however, a 140-bp
region of MNase resistance is detected, which is flanked on
each side by MNase-hypersensitive sites, suggesting the pres-
ence of a positioned nucleosome. The location of this nucleo-
some corresponds to a positioned nucleosome mapped be-
tween the GAL4 sites and the GAL1 TATA box of the
endogenous GAL1,10 locus (2, 6) (Fig. 4C and data not
shown). Thus, although one nucleosome still appears to be
positioned at this GAL1,10 UAS derivative, the majority of
nucleosome positioning has been lost. Consequently, nucleo-
somes appear to be located randomly upstream of the two
remaining GAL4 binding sites. In the absence of a positioned
array of nucleosomes, the two low-affinity GAL4 binding sites
are unlikely to reside in a constitutive nucleosome-free region.
MNase digestions and indirect end labeling were also used
to confirm that the NPE positioned a nucleosome upstream of
the two low-affinity GAL4 binding sites (Fig. 4B). Comparison
of the free and chromatin DNA samples reveals an MNase-
protected region of about 250 bp which contains the NPE
sequences as well as the MNase-resistant GAL4 binding site
sequences. This result is consistent with the positioning of a
nucleosome over the NPE sequence. In addition, the putative
positioned nucleosome located directly downstream of the two
low-affinity GAL4 binding sites is also detected at the NPE-
containing reporter locus in CY586 (Fig. 4B).
These results are consistent with the model shown in Fig. 6.
In the absence of the NPE, the two low-affinity GAL4 binding
sites are encompassed by randomly positioned nucleosomes;
FIG. 2. GAL4 can bind its sites in the GAL1,10 UAS region in the presence
or absence of SWI-SNF. In vivo DMS footprinting analysis of the GAL1,10 UAS
region was performed on strains CY341 (SWI1 GAL41) (lane 3), CY257 (swi12
GAL41) (lane 4), CY296 (SWI1 gal42) (lane 2), CY296 containing a GAL4
expression plasmid (pMA210 or pSD15) (lanes 6 and 8), and CY296 containing
a LexA expression plasmid (pEG202) (lane 7). Lane 1 contains a genomic
guanine sequencing ladder. Boxes to the left of the gel denote the GAL4 binding
sites of the GAL1,10 UAS, and asterisks denote guanine residues shown previ-
ously to be protected by GAL4 binding.
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insertion of the NPE repositions the GAL4 binding sites into a
nucleosome-free region between two positioned nucleosomes
(see Fig. 6). To further test the possibility that insertion of the
NPE changes the accessibility of the GAL4 binding sites, we
investigated the ability of a restriction enzyme to cleave a site
within GAL4 site 3 in permeabilized spheroplasts (Fig. 5).
Spheroplasts were prepared from the SWI1 strains CY532
(which contains the parental two-low-affinity-site reporter) and
CY586 (which harbors the NPE-containing two-low-affinity-
site reporter). Spheroplasts were made permeable by treat-
ment with nystatin (24) and incubated with HgaI restriction
endonuclease for 15 to 30 min. Genomic DNA was then
purified and digested to completion with HindIII, and the
HgaI-HindIII cleavage products were analyzed by Southern blot-
ting using a DNA probe from the GAL1 upstream region. This
DNA probe will detect the HgaI-HindIII cleavage products de-
rived from the GAL1,10 locus (1.6 kb) or the reporter locus (0.5
kb) in the same DNA sample (see the schematic in Fig. 5A). In
the case of the GAL1,10 locus, we expected that the HgaI site
within GAL4 site 3 would be highly accessible in permeabilized
spheroplasts, since this GAL4 site is known to be nucleosome-
free (6). In contrast, the model presented in Fig. 6 predicts that
the HgaI site at the parental two-low-affinity-site reporter will be
less accessible than the same site present at GAL1,10. Further-
more, the model predicts that insertion of the NPE will enhance
the accessibility of the HgaI site at the reporter locus.
Figure 5B shows the phosphorimager quantitation of a typ-
ical HgaI accessibility assay. At 15 and 30 min of digestion,
HgaI cleavage at the GAL1,10 locus was nearly complete (val-
ue set at 100%) (data not shown). However, in the case of the
FIG. 3. SWI-SNF is required for complete occupancy of two low-affinity GAL4 binding sites in vivo. In vivo DMS footprinting was performed on strains that harbor
the two-high-affinity-site reporter (A) or the two-low-affinity-site reporter (B). The strains used were as follows: for panel A, CY529 (gal42 SWI1) (lane 3), CY528
(GAL41 SWI1) (lane 4), and CY530 (GAL41 swi12) (lane 5); for panel B, CY533 (gal42 SWI1) (lane 2), CY532 (GAL41 SWI1) (lane 3), CY534 (GAL41 swi12)
(lane 4), CY532 harboring a GAL4 expression plasmid (lane 5), and CY534 harboring a GAL4 expression plasmid (lane 6). For quantitation of lanes 5 and 6 in panel
B, phosphorimager data were normalized to the doublet band indicated by the arrowhead (G449 and G450 [numbering from reference 30]). Symbols and lane 1 are
as described in the legend to Fig. 2.
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parental two-low-affinity-site reporter, cleavage of GAL4 site 3
by HgaI was less efficient, indicating that these sequences are
less accessible than they are at GAL1,10. Furthermore, inser-
tion of the NPE upstream of the GAL4 binding sites had a
dramatic effect on HgaI cleavage. Cleavage at the NPE-con-
taining reporter locus was at least threefold greater than the
parental reporter locus, and the cleavage appeared to be even
more efficient than cleavage at the GAL1,10 locus. These dif-
ferences in HgaI accessibility are not due to the binding of
GAL4, since similar results were also obtained when perme-
abilized spheroplasts were prepared from gal4 deletion strains
(data not shown). Thus, the accessibility of GAL4 site 3 to
HgaI cleavage correlates well with the nucleosome mapping
data and the SWI-SNF dependence of GAL4 activity (Fig. 6).
DISCUSSION
In vitro experiments have demonstrated that the SWI-SNF
complex can stimulate the binding of an activator protein to a
nucleosomal binding site (5, 16). Here we have tested whether
the complex exhibits this activity in vivo. We have shown that
the SWI-SNF complex facilitates the binding of GAL4 to two
low-affinity binding sites in vivo. Furthermore, we find that the
inability of GAL4 to occupy these low-affinity sites in the ab-
sence of SWI-SNF activity can be overcome by (i) replacing the
low-affinity binding sites with high-affinity GAL4 binding sites
or (ii) placing the low-affinity binding sites into a nucleosome-
free region. These results indicate that SWI-SNF is able to
facilitate GAL4 binding in vivo, perhaps by helping GAL4 to
FIG. 4. Nucleosome mapping of the two-low-affinity-site reporters with and
without an NPE. Free DNA and nuclei from the two low-affinity-site SWI1
reporter strain (CY532) (A) or the two-low-affinity-site, NPE-containing re-
porter strain (CY586) (B and C) were treated with increasing amounts of MNase
and nucleosome positioning at the reporter loci (A and B), or the GAL1,10 locus
(C) was analyzed by indirect end labeling. The following amounts of MNase (in
units per milliliter) were added: for panel A, 0 (lanes 1 and 7), 0.005 (lanes 2 and
8), 0.05 (lanes 3 and 9), 0.5 (lanes 4 and 10), 5 (lanes 5 and 11), 50 (lanes 6 and
12); for panel B, 0.5 (lanes 1 and 3) and 5 (lanes 2 and 4); for panel C, 1 (lane
1), 5 (lanes 2 and 3), and 25 (lane 4). The schematic to the right of each gel
depicts the mapped locus, black rectangles represent GAL4 binding sites, shaded
boxes represent coding sequence of the indicated gene, and shaded ovals rep-
resent the predicted positions of nucleosomes. Restriction sites used to generate
the probe fragment are indicated on the map accompanying each figure. In panel
C, primers used to amplify the probe fragment by PCR are indicated by black
bars. Migration of DNA size standards are noted to the left of each gel.
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compete more effectively with histones for occupancy of its
binding sites.
A definition of SWI-SNF dependence. Our results suggest
that the SWI-SNF dependence of a transcriptional activator
protein is not an innate feature of the activator protein per se
but rather reflects the chromosomal context of the activator
binding sites. We propose that when the activator binding sites
are encompassed in a nucleosome, as in the two-low-affinity-
site reporter used in this study, SWI-SNF function is necessary
for the activator protein to bind to and activate transcription
from those sites (Fig. 6). On the other hand, when binding sites
are nucleosome-free, as is the case at the GAL1,10 UAS region
or at the NPE-containing two-low-affinity-site reporter, then
SWI-SNF function is dispensable for GAL4 activity (Fig. 6). In
this case, GAL4 can bind to its sites and activate transcription
in the absence of SWI-SNF activity. Furthermore, SWI-SNF
dependence does not appear to correlate with the level of
transcriptional activation (i.e., promoter strength [Fig. 1A]).
Thus, based on the results presented here, we predict that the
subset of genes whose expression requires SWI-SNF will have
activator binding sites that are encompassed in nucleosomes;
genes that do not require SWI-SNF will have such sites posi-
tioned in the linker regions between nucleosomes or in other
nucleosome-free regions. This positioning may be determined
by DNA sequence, as in the NPE-containing reporter, or by
abundant DNA binding proteins like GRF2, as in the case of
the intact GAL1,10 reporter.
Our results also require that binding site affinity be incor-
porated into the definition of SWI-SNF dependence. While
GAL4 requires SWI-SNF in order to access two low-affinity
FIG. 5. An NPE leads to enhanced accessibility of a GAL4 binding site. (A) Schematic of the GAL1,10 and reporter loci. The black bar denotes the DNA fragment
used as a probe in Southern blotting. The HgaI site is located at the 39 end of GAL4 site 3. 1/2 NPE, with or without an NPE. (B) HgaI accessibility assay. HgaI was
added to nystatin-permeabilized spheroplasts prepared from SWI1 strains harboring either the parental two-low-affinity-site reporter (2 NPE; CY532) or the
NPE-containing two-low-affinity-site reporter (1 NPE; CY586). DNA digested in situ was purified, digested to completion with HindIII, and analyzed by Southern
blotting using the DNA probe denoted in panel A. Phosphorimager quantitation of the HgaI-HindIII fragments is shown for the 15- and 30-min HgaI digestion time
points. The yields of the 0.5-kb HgaI-HindIII fragments from the two different reporter loci are presented as a percentage of the 1.6-kb HgaI-HindIII fragment derived
from the GAL1,10 locus which was set at 100% accessibility.
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binding sites, high-affinity sites are occupied even in the ab-
sence of SWI-SNF. The ability of higher-affinity binding sites
to alleviate SWI-SNF dependence provides strong evidence
that the SWI-SNF complex modulates transactivation at the
level of DNA binding. Furthermore, if these high-affinity bind-
ing sites are encompassed by nucleosomes, then our results
suggest that GAL4 binding to high-affinity, nucleosomal sites
can occur in vivo via a SWI-SNF-independent mechanism.
These results are consistent with those of Workman and King-
ston (28), who found that GAL4 can bind to a nucleosomal site
to form a tripartite transcription factor-histone-DNA complex.
Does the SWI-SNF complex play an additional role in tran-
scriptional activation? As noted above, we detect a consistent
level of GAL4 binding to the low-affinity sites in the swi12
strain (Fig. 3B, compare lanes 5 and 6); phosphorimager anal-
ysis indicates site 3 may be occupied at 60% of the level seen
in a SWI1 strain (Fig. 3C). The fact that this level of occupancy
results in negligible levels of transcription (3% of wild-type
level [Fig. 1A, reporter c]) may indicate a role for the SWI-
SNF complex in transcriptional activation beyond the modu-
lation of activator binding. In light of recent reports suggesting
that the SWI-SNF complex may associate with the RNA poly-
merase II holoenzyme (25), it is interesting to consider the
possibility that an activator–SWI-SNF interaction is involved in
preinitiation complex assembly. On the other hand, our in vivo
footprinting procedure does not allow us to determine the
extent to which site 3 and site 4 are simultaneously occupied
and we cannot distinguish whether the 60% occupancy in a
swi-snf strain reflects the stable binding of GAL4 in 60% of the
cells or reflects weak, unstable binding in 100% of the cells.
Therefore, our results may support an additional role for the
SWI-SNF complex in facilitating the cooperative binding of
GAL4 or in enhancing the stability of GAL4 binding to low-
affinity, nucleosomal sites in vivo.
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